1,2,4,5-Tetrafluoro-3-methoxy-6-nitrobenzene, 98%, 250mg

Potassium 3-(tert-butyl)-1,2,4-oxadiazole-5-carboxylate, 95%, 100mg

2-(3-Fluoro-4-(methylthio)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

1,1'-Bis(4-formylphenyl)-[4,4'-bipyridine]-1,1'-diium, 98%, 50mg

Pyrazolo[1,5-a]pyridine-5-carbonitrile, 95%, 1g

Methyl 2-acetylisonicotinate, 95.0%, 5g

3-Amino-2-hydroxypyridine, 99.0%, 100g

5-Acetyl-2-methylpyridine, 97.0%, 10g

N*1*-(3-Bromo-benzyl)-N*1*-ethyl-ethane-1,2-diamine, 97%, 5g

1-Bromo-3-cyclobutylbenzene, 97.0%, 1g

4-sec-butoxy-3-chloro-5-methoxybenzaldehyde, 95.0%, 1g

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)morpholine, 95.0%, 100mg

Trial kit Spectra/Por® 1-3 Spectra/Por® 2 - MWCO 12,000–14,000, 25 mm, 1 Piece(s)